Polycystic kidney disease trials in United Kingdom
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleHypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease
- Where
- London
- Age
- 12 years to 17 years
- People
- 200
- Run by
- King's College London
See details and how to joinNCT07260071 - Phase 3Taking peopleA Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
- Where
- London
- Age
- 28 days to 18 years
- People
- 20 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT04782258 · EU 2023-508218-41-00 - Phase 1Taking peopleSafety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
- Where
- London
- Age
- 18 years to 65 years
- People
- 40 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07228364 - Phase 3Taking peopleImplementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
- Where
- Antrim, Belfast, Birmingham, Bradford, Cardiff, Carshalton, Doncaster, Exeter, Inverness, Leicester, Liverpool, London, Londonderry, Newcastle upon Tyne, Newry, Norwich, Nottingham, Oxford, Plymouth, Preston, Salford, Sheffield, Stevenage, Stoke-on-Trent, Sunderland, York
- Age
- 18 years to 70 years
- People
- 1,174 worldwide
- Run by
- The University of Queensland
See details and how to joinNCT04939935 - No phaseTaking peopleNational Registry of Rare Kidney Diseases
- Where
- Bristol
- People
- 35,000
- Run by
- UK Kidney Association
See details and how to joinNCT06065852